Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
HeartBeam, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BEAT
Nasdaq
3840
www.heartbeam.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for HeartBeam, Inc.
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
- Apr 29th, 2025 12:31 pm
HeartBeam partners with AccurKardia to enhance cardiac care
- Apr 25th, 2025 1:18 pm
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
- Apr 24th, 2025 12:31 pm
Q4 2024 Heartbeam Inc Earnings Call
- Mar 14th, 2025 5:41 pm
HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves
- Mar 14th, 2025 7:10 am
HeartBeam Reports Fourth Quarter and Full Year 2024 Results
- Mar 13th, 2025 8:01 pm
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
- Mar 6th, 2025 2:01 pm
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
- Feb 27th, 2025 1:31 pm
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
- Feb 25th, 2025 9:01 pm
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
- Feb 13th, 2025 1:31 pm
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks
- Jan 31st, 2025 8:12 pm
HeartBeam submits 510(k) application to FDA for ECG software
- Jan 30th, 2025 10:04 am
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
- Jan 29th, 2025 1:31 pm
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
- Dec 23rd, 2024 1:31 pm
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance
- Dec 17th, 2024 9:30 am
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
- Dec 16th, 2024 1:31 pm
HeartBeam And 2 Other US Penny Stocks With Promising Potential
- Dec 4th, 2024 5:10 pm
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
- Nov 19th, 2024 1:31 pm
HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...
- Nov 8th, 2024 11:01 pm
HeartBeam Reports Third Quarter 2024 Results
- Nov 7th, 2024 9:05 pm
Scroll